Crypto Tax Break Provisions Excluded from Trump’s “Beautiful Law Act”
According to a report by Jinse Finance, on Tuesday local time, the U.S. Senate narrowly passed President Donald Trump’s “Beautiful Act.” However, to the disappointment of crypto industry leaders, the bill failed to include the key tax amendment for crypto users that they had previously advocated for. In the final hours of intense negotiations before the bill’s passage, pro-crypto senators led by Cynthia Lummis (Republican, Wyoming) and industry policy leaders made efforts to attach an amendment containing several crypto-related tax incentives to the bill. These incentives would have benefited crypto miners, stakers, enterprises holding large amounts of cryptocurrency, and ordinary digital asset users. Ultimately, time ran out and the amendment was not brought to the Senate for consideration. A crypto policy leader described the outcome as a “missed opportunity,” stating that they “simply ran out of time.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Korean retail investors shift to the US in Q3: Sold over 5.5 trillion won of Korean stocks, purchased more than 10 trillion won of US stocks
In the third quarter, Korean retail investors made net purchases of US stocks worth approximately 10.15 trillion won, marking a complete reversal from the previous pattern in the first half of the year, when they made net purchases of nearly 100 trillion won in KOSPI stocks. In September alone, the sell-off amount reached as high as 14.2 trillion won. Analysts attribute this shift to a combination of factors: a sharp decline in KOSPI at high levels, the continued strength of the US stock market driven by AI themes, and the appreciation of the Korean won reducing currency exchange costs.
Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
